REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 10 filers reported holding REGENERON PHARMACEUTICALS in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,119 | +119.6% | 11,300 | +151.1% | 0.08% | +68.9% |
| Q1 2023 | $3,697 | -99.1% | 4,500 | +542.9% | 0.04% | +800.0% |
| Q2 2022 | $413,000 | -73.7% | 700 | -73.1% | 0.01% | -50.0% |
| Q3 2021 | $1,573,000 | -51.8% | 2,600 | -62.3% | 0.01% | -69.7% |
| Q1 2021 | $3,264,000 | +71.5% | 6,900 | +102.9% | 0.03% | -40.0% |
| Q3 2020 | $1,903,000 | +88.4% | 3,400 | +36.0% | 0.06% | -65.0% |
| Q3 2018 | $1,010,000 | – | 2,500 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,198 | $80,686,000 | 4.69% |
| SIMPLEX TRADING, LLC | 1,029 | $1,326,000 | 0.08% |
| Allianz Asset Management GmbH | 205,300 | $75,364,000 | 0.07% |
| Timber Hill LLC | 22,300 | $8,186,000 | 0.04% |